| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |